<DOC>
	<DOCNO>NCT02463578</DOCNO>
	<brief_summary>Exploratory study anti-pneumococcal immune response patient Anti-neutrophil cytoplasmic antibody ( ANCA ) -associated vasculitis ( AAV ) immunize accord new vaccine recommendation ( i.e . combine vaccine schedule ( 13-valent conjugate pneumococcal vaccine -PCV13- follow 23-valent non-conjugate pneumococcal vaccine -PPV23- 8 week later ) .</brief_summary>
	<brief_title>Immunogenicity Combined Anti-pneumococcal Vaccine Schedule Patients With ANCA-associated Vasculitis</brief_title>
	<detailed_description>The purpose study determine whether vaccination schedule induces sufficient protective immunity ( serotype-specific enzyme link immunosorbent assay ( ELISA ) opsonophagocytosis ( OPA ) response rate ) AAV-patients receive immunosuppressive therapy .</detailed_description>
	<mesh_term>Vasculitis</mesh_term>
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Age ≥ 18 year ANCAassociated vasculitis : diagnosis granulomatosis polyangiitis , microscopic polyangiitis eosinophilic granulomatosis polyangiitis accord American College Rheumatology criterion Indication pneumococcal vaccination accord French recommendation ( statement Haut Conseil de Santé Publique regard pneumococcal vaccination adult child older 2 year old risk invasive pneumococcal disease , April 25Th 2013 ) History pneumococcal immunization 36 month 24hours VO . Patients know , suspected pregnancy Patients planning get pregnant year follow inclusion Splenectomy Eosinophilic granulomatosis polyangiitis ( EGPA , ChurgStrauss ) flare Infection week inclusion Patient without social security coverage Individuals opposal</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Pneumococcal infection</keyword>
	<keyword>Invasive pneumococcal disease ( IPD )</keyword>
	<keyword>Pneumococcal vaccine</keyword>
	<keyword>Vaccinology</keyword>
	<keyword>Immunocompromised</keyword>
	<keyword>Auto-immune disease</keyword>
	<keyword>Systemic vasculitis</keyword>
	<keyword>ANCA-associated vasculitis</keyword>
</DOC>